Sustained release tablets containing bupropion

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/135 (2006.01) A61K 9/20 (2006.01) A61K 9/22 (2006.01) A61K 47/18 (2006.01) A61K 47/38 (2006.01)

Patent

CA 2142320

A controlled sustained release tablet having at least one year shelf life and containing bupropion hydrochloride, hydroxyp- ropyl methylcellulose and cysteine hydrochloride or glycine hydrochloride with the tablet having a surface area to volume ratio to effectively control bupropion hydrochloride release in the body.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Sustained release tablets containing bupropion does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sustained release tablets containing bupropion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release tablets containing bupropion will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1707705

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.